{
  "trial_id": "NCT02839720",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, hemoglobin level, absolute neutrophil count, platelet count, total bilirubin level, alanine transferase (ALT) level, creatinine level, presence of cafe-au-lait macules, presence of freckling in axilla or groin, presence of optic glioma, presence of Lisch nodules, presence of distinctive bony lesions, family history of NF1, number of measurable cutaneous neurofibromas, prior medical therapy for NF1, prior radiation therapy, prior surgeries, use of contraception, pregnancy status, history of cardiac disorders, history of ophthalmologic conditions, history of hypersensitivity to selumetinib, history of chronic gastrointestinal diseases, use of strong inhibitors or inducers of hepatic microsomal isoenzymes.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Average cutaneous neurofibroma (cNF) volume",
          "number of measurable cutaneous neurofibromas"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "hemoglobin level",
        "absolute neutrophil count",
        "platelet count",
        "total bilirubin level",
        "alanine transferase (ALT) level",
        "creatinine level",
        "presence of cafe-au-lait macules",
        "presence of freckling in axilla or groin",
        "presence of optic glioma",
        "presence of Lisch nodules",
        "presence of distinctive bony lesions",
        "family history of NF1",
        "prior medical therapy for NF1",
        "prior radiation therapy",
        "prior surgeries",
        "use of contraception",
        "pregnancy status",
        "history of cardiac disorders",
        "history of ophthalmologic conditions",
        "history of hypersensitivity to selumetinib",
        "history of chronic gastrointestinal diseases",
        "use of strong inhibitors or inducers of hepatic microsomal isoenzymes."
      ]
    },
    "processed-gen-response": "Age, gender, race, ECOG performance status, hemoglobin level, absolute neutrophil count, platelet count, total bilirubin level, alanine transferase (ALT) level, creatinine level, presence of cafe-au-lait macules, presence of freckling in axilla or groin, presence of optic glioma, presence of Lisch nodules, presence of distinctive bony lesions, family history of NF1, number of measurable cutaneous neurofibromas, prior medical therapy for NF1, prior radiation therapy, prior surgeries, use of contraception, pregnancy status, history of cardiac disorders, history of ophthalmologic conditions, history of hypersensitivity to selumetinib, history of chronic gastrointestinal diseases, use of strong inhibitors or inducers of hepatic microsomal isoenzymes."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, Hemoglobin, Absolute neutrophil count, Platelet count, Total bilirubin, Alanine transferase (ALT), Creatinine, Number of measurable cutaneous neurofibromas, Presence of cafe-au-lait macules, Presence of freckling in axilla or groin, Presence of optic glioma, Presence of Lisch nodules, Presence of distinctive bony lesion, Family history of NF1,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Average cutaneous neurofibroma (cNF) volume",
          "Number of measurable cutaneous neurofibromas"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Hemoglobin",
        "Absolute neutrophil count",
        "Platelet count",
        "Total bilirubin",
        "Alanine transferase (ALT)",
        "Creatinine",
        "Presence of cafe-au-lait macules",
        "Presence of freckling in axilla or groin",
        "Presence of optic glioma",
        "Presence of Lisch nodules",
        "Presence of distinctive bony lesion",
        "Family history of NF1"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG performance status, Hemoglobin, Absolute neutrophil count, Platelet count, Total bilirubin, Alanine transferase (ALT), Creatinine, Number of measurable cutaneous neurofibromas, Presence of cafe-au-lait macules, Presence of freckling in axilla or groin, Presence of optic glioma, Presence of Lisch nodules, Presence of distinctive bony lesion, Family history of NF1"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, NF1 mutation status, Number of cafe-au-lait macules, Presence of freckling in axilla or groin, Presence of optic glioma, Number of Lisch nodules, Presence of distinctive bony lesion, Family history of NF1, ECOG performance status, Hemoglobin, Absolute neutrophil count, Platelets, Total bilirubin, ALT, Creatinine, Creatinine clearance, Presence of substantial cutaneous neurofibroma burden, Number of measurable cutaneous neurofibromas.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Average cutaneous neurofibroma (cNF) volume"
      ],
      "remaining_candidate_features": [
        "NF1 mutation status",
        "Number of cafe-au-lait macules",
        "Presence of freckling in axilla or groin",
        "Presence of optic glioma",
        "Number of Lisch nodules",
        "Presence of distinctive bony lesion",
        "Family history of NF1",
        "ECOG performance status",
        "Hemoglobin",
        "Absolute neutrophil count",
        "Platelets",
        "Total bilirubin",
        "ALT",
        "Creatinine",
        "Creatinine clearance",
        "Presence of substantial cutaneous neurofibroma burden",
        "Number of measurable cutaneous neurofibromas"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, NF1 mutation status, Number of cafe-au-lait macules, Presence of freckling in axilla or groin, Presence of optic glioma, Number of Lisch nodules, Presence of distinctive bony lesion, Family history of NF1, ECOG performance status, Hemoglobin, Absolute neutrophil count, Platelets, Total bilirubin, ALT, Creatinine, Creatinine clearance, Presence of substantial cutaneous neurofibroma burden, Number of measurable cutaneous neurofibromas."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), ECOG performance status, hemoglobin, absolute neutrophil count, platelets, total bilirubin, ALT, creatinine, creatinine clearance, presence of cafe-au-lait macules, freckling in axilla or groin, optic glioma, Lisch nodules, bony lesions, family history of NF1, number and size of cutaneous neurofibromas, presence of substantial cutaneous neurofibroma burden, prior medical therapy directed at NF1 related tumor manifestations, prior radiation therapy, prior surgery.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "ECOG performance status",
          "ECOG performance status"
        ],
        [
          "Average cutaneous neurofibroma (cNF) volume",
          "number and size of cutaneous neurofibromas"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "hemoglobin",
        "absolute neutrophil count",
        "platelets",
        "total bilirubin",
        "ALT",
        "creatinine",
        "creatinine clearance",
        "presence of cafe-au-lait macules",
        "freckling in axilla or groin",
        "optic glioma",
        "Lisch nodules",
        "bony lesions",
        "family history of NF1",
        "presence of substantial cutaneous neurofibroma burden",
        "prior medical therapy directed at NF1 related tumor manifestations",
        "prior radiation therapy",
        "prior surgery"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), ECOG performance status, hemoglobin, absolute neutrophil count, platelets, total bilirubin, ALT, creatinine, creatinine clearance, presence of cafe-au-lait macules, freckling in axilla or groin, optic glioma, Lisch nodules, bony lesions, family history of NF1, number and size of cutaneous neurofibromas, presence of substantial cutaneous neurofibroma burden, prior medical therapy directed at NF1 related tumor manifestations, prior radiation therapy, prior surgery."
  }
}